We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

HospiMedica

Download Mobile App
Recent News AI Critical Care Surgical Techniques Patient Care Health IT Point of Care Business Focus

Novel POC Hemolysis System Improves Patient Care, Reduces Workload for Emergency Departments and ICUs

By HospiMedica International staff writers
Posted on 13 Nov 2022
Print article
Image: Helge is a patented CE-marked concept for point of care hemolysis detection (Photo courtesy of Hemcheck Sweden)
Image: Helge is a patented CE-marked concept for point of care hemolysis detection (Photo courtesy of Hemcheck Sweden)

Hemolysis, or the rupturing of red blood cells, is the most common reason why a blood sample is deemed unfit for laboratory analysis. Every year, billions of blood samples are taken globally that are hemolyzed, while the majority of all medical decisions are based on results from blood test analysis. Missing or incorrect test results can lead to delayed treatment, spiraling healthcare costs, increased workloads for healthcare professionals and above all, unnecessary suffering for patients. For point of care analyses, such as blood gas analyses, results are released without checking for hemolysis. At the same time, there is scientific evidence that a large amount of blood samples are hemolysed and that hemolysis changes the analysis results for important analytes. For example, the analysis results may be falsely normal, while the actual values are completely different. This can lead to missing, incorrect or delayed care for patients with acute conditions. For some patient groups intravascular hemolysis is an important problem which can lead to adverse outcomes, and that needs to be detected and treated.

Now, an innovative product concept from Hemcheck Sweden AB (Solna, Sweden) enables the detection of hemolysed blood samples in direct connection with blood sampling near the patient, contributing to increased patient safety, more efficient processes and lower costs. Hemcheck operations are based around the Helge product concept. The product consists of three different disposable tests, v-Test for vacuum tubes and s-Test and bgs-Test for blood gas syringes, both of which can be used in the same reader.

For easy and user-friendly reading of disposable v-, bgs- and s-Tests, there is a common reader that, with a simple push of a button, signals if the blood sample is Hemolyzed or not. The aim is to identify hemolyzed blood samples at the time of sampling (point of care) and with the same quality as a laboratory. With an accessory screen connected to the reader, the user can determine the amount of free hemoglobin in the blood sample. The reader is mobile, easy to clean and can easily sit on a trolley or next to a blood gas analysis instrument. Today it can take up to one hour for a blood sample result to come back from the laboratory to the sampler. Helge performs the same analysis in a matter of seconds, opening up new possibilities for assessing blood sample quality and helping determining patient diagnosis.

Related Links:
Hemcheck Sweden AB 

Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Silver Member
Wireless Mobile ECG Recorder
NR-1207-3/NR-1207-E
New
Baby Warmer
THERMOCARE Convenience

Print article

Channels

Critical Care

view channel
Image: The stretchable microneedle electrode arrays (Photo courtesy of Zhao Research Group)

Stretchable Microneedles to Help In Accurate Tracking of Abnormalities and Identifying Rapid Treatment

The field of personalized medicine is transforming rapidly, with advancements like wearable devices and home testing kits making it increasingly easy to monitor a wide range of health metrics, from heart... Read more

Surgical Techniques

view channel
Image: NICO SPECTRA is only hand-held technology delivering blue light closer to target to enhance tissue fluorescence (Photo courtesy of NICO Corporation)

Handheld Device for Fluorescence-Guided Surgery a Game Changer for Removal of High-Grade Glioma Brain Tumors

Grade III or IV gliomas are among the most common and deadly brain tumors, with around 20,000 cases annually in the U.S. and 1.2 million globally. These tumors are very aggressive and tend to infiltrate... Read more

Patient Care

view channel
Image: The portable, handheld BeamClean technology inactivates pathogens on commonly touched surfaces in seconds (Photo courtesy of Freestyle Partners)

First-Of-Its-Kind Portable Germicidal Light Technology Disinfects High-Touch Clinical Surfaces in Seconds

Reducing healthcare-acquired infections (HAIs) remains a pressing issue within global healthcare systems. In the United States alone, 1.7 million patients contract HAIs annually, leading to approximately... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more